NLS Pharmaceutics Ltd. - Ordinary Shares (NQ:NLSP)

0.7620 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NLS Pharmaceutics Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Why Is Actelis Networks (ASNS) Stock Up 144% Today? ↗

June 18, 2024

Actelis Networks stock is up with heavy trading of ASNS shares after signing Carahsoft Technology as a new supply partner.

Via InvestorPlace

Why Is NLS Pharmaceutics (NLSP) Stock Up 163% Today? ↗

June 18, 2024

NLS Pharmaceutics stock is up on Tuesday with heavy trading of NLSP shares despite a lack of news from the company this morning.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 18, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!

Via InvestorPlace

Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

June 18, 2024

Via Benzinga

NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)

June 11, 2024

Via ACCESSWIRE

NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model

May 28, 2024

Via ACCESSWIRE

NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq

May 24, 2024

Via ACCESSWIRE

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

April 19, 2024

Via ACCESSWIRE

NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering

March 22, 2024

Via ACCESSWIRE

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

March 20, 2024

Via ACCESSWIRE

NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform

March 20, 2024

Via ACCESSWIRE

NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event

March 14, 2024

Via ACCESSWIRE

Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance

March 11, 2024

Via ACCESSWIRE

NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq

February 23, 2024

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 29, 2024

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

Notice of Deficiency with Nasdaq Continued Listing Requirements

January 12, 2024

Via ACCESSWIRE

NLS Pharmaceutics CEO Issues Letter to Shareholders

December 29, 2023

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 06, 2023

It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!

Via InvestorPlace

Spotify Layoffs 2023: What to Know About the Latest SPOT Job Cuts ↗

December 04, 2023

Spotify layoffs are on the way for 17% of the company's workforce as it prepares to reduce headcount to cut operational costs.

Via InvestorPlace

Topics Workforce

Evercore ISI Is Souring on Fisker (FSR) Stock ↗

December 04, 2023

Fisker stock is falling on Monday after shares of FSR were hit with a downgrade and a lowered price target by Evercore ISI.

Via InvestorPlace

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

Why Is Garden Stage (GSIW) Stock Down 38% Today? ↗

December 04, 2023

Garden Stage stock is dropping on Monday following a rally on Friday when shares of GSIW started trading alongside its IPO.

Via InvestorPlace

Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today? ↗

December 04, 2023

NLS Pharmaceutics stock is falling on Monday after shares of NLSP stock underwent a strong rally with heavy trading on Friday.

Via InvestorPlace

Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket ↗

December 04, 2023

Shares of Hawaiian Airlines (NASDAQ: HA) shares rose sharply in pre-market trading after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 04, 2023

It's time to start of the trading week with a look at the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.

December 01, 2023

Via ACCESSWIRE

NLS Pharmaceutics Announces Election of Additional Board Members

November 28, 2023

Via ACCESSWIRE

NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia

November 27, 2023

Via ACCESSWIRE

Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 16, 2023

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

Via Benzinga

Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today ↗

November 16, 2023

NLS Pharmaceutics AG (NASDAQ: NLSP) shares are trading lower by 40% to $0.30 Thursday morning after the company announced it is seeking strategic alternatives to enhance shareholder value by exploring...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.